SpringWorks Therapeutics, Inc. (SWTX) NASDAQ
$37.48 1.49 (4.13%)
Market Cap: $2.78B
As of 09/13/24 11:59 AM EDT. Market open.
SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ
$37.48
1.49 (4.13%)
Market Cap: $2.78B
As of 09/13/24 11:59 AM EDT. Market open.
Add to Portfolio
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also developing mirdametinib, an oral small molecule MEK ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Saqib Islam J.D.
Full Time Employees
305
CEO Compensation (Base)
$725,000
CEO Compensation (Total)
$18.35M
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Saqib Islam J.D.
Full Time Employees
305
CEO Compensation (Base)
$725,000
CEO Compensation (Total)
$18.35M
Address
100 Washington Boulevard, CT, Stamford, 06902.
PRICE CHART FOR SPRINGWORKS THERAPEUTICS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$36.03
Previous Close
$35.99
Days Range
$35.75 - $37.48
52 week range
$18 - $53.92
Volume
234,463
Avg. Volume (30 days)
844,312
Market Cap
$2.78B
Dividend Yield
-
P/E
(8.44)
Shares Outstanding
74,273,000
Open
$36.03
Previous Close
$35.99
Days Range
$35.75 - $37.48
52 week range
$18 - $53.92
Volume
234,463
Avg. Volume (30 days)
844,312
Market Cap
$2.78B
Dividend Yield
-
P/E
(8.44)
Shares Outstanding
74,273,000
FINANCIAL STATEMENTS FOR SPRINGWORKS THERAPEUTICS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SPRINGWORKS THERAPEUTICS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Islam Saqib | Chief Executive Officer | Sep 03, 2024 | Sale | $40.57 | 49,000 | 1,988,033 | 1,079,968 | Sep 04, 2024, 04:05 PM |
| Edris Badreddin | Chief Operating Officer | Sep 03, 2024 | Sale | $40.65 | 20,000 | 812,954 | 237,300 | Sep 04, 2024, 04:05 PM |
| Cassidy James | Chief Medical Officer | Aug 30, 2024 | Option Exercise | $41.71 | 1,969 | 82,127 | 73,856 | Sep 03, 2024, 04:05 PM |
| Cassidy James | Chief Medical Officer | Jul 01, 2024 | Option Exercise | $38.53 | 591 | 22,771 | 75,825 | Jul 02, 2024, 04:12 PM |
| Islam Saqib | Chief Executive Officer | Jun 03, 2024 | Sale | $39.90 | 49,000 | 1,955,113 | 1,128,128 | Jun 05, 2024, 04:08 PM |
| Hambleton Julie | Director | Jun 03, 2024 | Sale | $40.03 | 4,648 | 186,048 | 5,797 | Jun 05, 2024, 04:08 PM |
| Edris Badreddin | Chief Operating Officer | Jun 03, 2024 | Sale | $40.07 | 20,000 | 801,372 | 257,828 | Jun 05, 2024, 04:07 PM |
| Ashar Bhavesh | Chief Commercial Officer | Apr 01, 2024 | Option Exercise | $47.62 | 1,824 | 86,859 | 56,330 | Apr 03, 2024, 04:01 PM |
| Pichl Daniel | Chief People Officer | Feb 16, 2024 | Option Exercise | $27.64 | 15,000 | 414,600 | 60,212 | Feb 20, 2024, 06:56 PM |
| Pichl Daniel | Chief People Officer | Feb 16, 2024 | Sale | $50.10 | 15,000 | 751,549 | 45,212 | Feb 20, 2024, 06:56 PM |
| Ashar Bhavesh | Chief Commercial Officer | Feb 05, 2024 | Sale | $49.32 | 4,834 | 238,435 | 58,154 | Feb 05, 2024, 09:24 PM |
| Ashar Bhavesh | Chief Commercial Officer | Feb 02, 2024 | Sale | $44.37 | 3,222 | 142,976 | 65,121 | Feb 05, 2024, 09:24 PM |
| Pichl Daniel | Chief People Officer | Feb 02, 2024 | Option Exercise | $27.64 | 16,250 | 449,150 | 71,393 | Feb 05, 2024, 09:23 PM |
| Pichl Daniel | Chief People Officer | Feb 02, 2024 | Sale | $44.32 | 26,181 | 1,160,362 | 62,127 | Feb 05, 2024, 09:23 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 05, 2024 | Option Exercise | $37.96 | 2,324 | 88,219 | 54,662 | Jan 08, 2024, 09:13 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 08, 2024 | Option Exercise | $41.53 | 2,423 | 100,627 | 52,239 | Jan 08, 2024, 09:13 PM |
| Smith L. Mary | Chief Development Officer | Jan 08, 2024 | Option Exercise | $41.53 | 3,535 | 146,809 | 233,363 | Jan 08, 2024, 09:13 PM |
| Smith L. Mary | Chief Development Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,197 | 83,398 | 236,898 | Jan 08, 2024, 09:13 PM |
| Islam Saqib | Chief Executive Officer | Jan 08, 2024 | Option Exercise | $41.53 | 17,904 | 743,553 | 256,264 | Jan 08, 2024, 09:12 PM |
| Islam Saqib | Chief Executive Officer | Jan 05, 2024 | Option Exercise | $37.96 | 12,885 | 489,115 | 274,168 | Jan 08, 2024, 09:12 PM |
| Pichl Daniel | Chief People Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,405 | 58,350 | 55,143 | Jan 08, 2024, 09:12 PM |
| Pichl Daniel | Chief People Officer | Jan 05, 2024 | Option Exercise | $37.96 | 1,574 | 59,749 | 56,548 | Jan 08, 2024, 09:12 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 08, 2024 | Option Exercise | $41.53 | 3,215 | 133,519 | 59,253 | Jan 08, 2024, 09:11 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,151 | 81,652 | 62,468 | Jan 08, 2024, 09:11 PM |
| Nofi Michael | Chief Accounting Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,063 | 44,146 | 28,727 | Jan 08, 2024, 09:11 PM |
| Nofi Michael | Chief Accounting Officer | Jan 05, 2024 | Option Exercise | $37.96 | 1,169 | 44,375 | 29,790 | Jan 08, 2024, 09:11 PM |
| Edris Badreddin | Chief Operating Officer | Jan 08, 2024 | Option Exercise | $41.53 | 5,466 | 227,003 | 269,600 | Jan 08, 2024, 09:09 PM |
| Edris Badreddin | Chief Operating Officer | Jan 05, 2024 | Option Exercise | $37.96 | 4,469 | 169,643 | 275,066 | Jan 08, 2024, 09:09 PM |
| Cassidy James | Chief Medical Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,093 | 45,392 | 76,416 | Jan 08, 2024, 09:07 PM |
| Cassidy James | Chief Medical Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,357 | 89,472 | 77,509 | Jan 08, 2024, 09:07 PM |
| Ashar Bhavesh | Chief Commercial Officer | Jan 08, 2024 | Option Exercise | $41.53 | 1,449 | 60,177 | 66,210 | Jan 08, 2024, 09:06 PM |
| Ashar Bhavesh | Chief Commercial Officer | Jan 05, 2024 | Option Exercise | $37.96 | 2,507 | 95,166 | 67,659 | Jan 08, 2024, 09:06 PM |
| Cassidy James | Chief Medical Officer | Sep 01, 2023 | Option Exercise | $30.33 | 1,292 | 39,186 | 51,658 | Sep 08, 2023, 04:05 PM |
| Hambleton Julie | Director | Jul 19, 2023 | Sale | $29.31 | 2,418 | 70,876 | 4,648 | Jul 21, 2023, 04:13 PM |
| Hambleton Julie | Director | Jun 20, 2023 | Sale | $26.92 | 2,400 | 64,603 | 7,066 | Jun 22, 2023, 04:06 PM |
| Ashar Bhavesh | Chief Commercial Officer | Apr 03, 2023 | Option Exercise | $25.25 | 1,375 | 34,719 | 43,721 | Apr 05, 2023, 04:46 PM |
| Schwartz Jeffrey Lawrence | Director | Mar 16, 2023 | Sale | $28.50 | 1,750,000 | 49,875,000 | 3,081,307 | Mar 20, 2023, 05:00 PM |
| Hambleton Julie | Director | Mar 15, 2023 | Sale | $31.50 | 1,106 | 34,841 | 4,818 | Mar 16, 2023, 04:31 PM |
| Pichl Daniel | Chief People Officer | Jan 26, 2023 | Sale | $31.00 | 858 | 26,598 | 35,203 | Jan 27, 2023, 04:30 PM |
| Nofi Michael | Chief Accounting Officer | Jan 07, 2023 | Option Exercise | $26.41 | 409 | 10,802 | 16,855 | Jan 10, 2023, 04:08 PM |
| Islam Saqib | Chief Executive Officer | Jan 07, 2023 | Option Exercise | $26.41 | 4,097 | 108,202 | 905,104 | Jan 10, 2023, 04:07 PM |
| Edris Badreddin | Chief Operating Officer | Jan 07, 2023 | Option Exercise | $26.41 | 1,483 | 39,166 | 237,223 | Jan 10, 2023, 04:05 PM |
| Pichl Daniel | Chief People Officer | Jan 07, 2023 | Option Exercise | $26.41 | 546 | 14,420 | 36,061 | Jan 10, 2023, 04:02 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 07, 2023 | Option Exercise | $26.41 | 1,090 | 28,787 | 43,463 | Jan 10, 2023, 04:02 PM |
| Smith L. Mary | Chief Development Officer | Jan 07, 2023 | Option Exercise | $26.41 | 1,068 | 28,206 | 212,219 | Jan 10, 2023, 04:01 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 07, 2023 | Option Exercise | $26.41 | 909 | 24,007 | 35,830 | Jan 10, 2023, 04:01 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 06, 2023 | Option Exercise | $27.52 | 2,374 | 65,332 | 44,553 | Jan 09, 2023, 05:01 PM |
| Islam Saqib | Chief Executive Officer | Jan 06, 2023 | Option Exercise | $27.52 | 8,400 | 231,168 | 909,201 | Jan 09, 2023, 05:01 PM |
| Edris Badreddin | Chief Operating Officer | Jan 06, 2023 | Option Exercise | $27.52 | 3,326 | 91,532 | 238,706 | Jan 09, 2023, 05:01 PM |
| Cassidy James | Chief Medical Officer | Jan 06, 2023 | Option Exercise | $27.52 | 1,263 | 34,758 | 47,230 | Jan 09, 2023, 05:00 PM |
| Smith L. Mary | Chief Development Officer | Jan 06, 2023 | Option Exercise | $27.52 | 2,452 | 67,479 | 213,287 | Jan 09, 2023, 05:00 PM |
| Nofi Michael | Chief Accounting Officer | Jan 06, 2023 | Option Exercise | $27.52 | 783 | 21,548 | 17,264 | Jan 09, 2023, 05:00 PM |
| Ashar Bhavesh | Chief Commercial Officer | Jan 06, 2023 | Option Exercise | $27.52 | 1,665 | 45,821 | 45,096 | Jan 09, 2023, 05:00 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 06, 2023 | Option Exercise | $27.52 | 1,782 | 49,041 | 36,739 | Jan 09, 2023, 04:59 PM |
| Pichl Daniel | Chief People Officer | Jan 06, 2023 | Option Exercise | $27.52 | 1,719 | 47,307 | 36,607 | Jan 09, 2023, 04:59 PM |
| Ashar Bhavesh | Chief Commercial Officer | Apr 01, 2022 | Option Exercise | $56.90 | 1,464 | 83,302 | 24,098 | Oct 13, 2022, 04:03 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Sep 12, 2022 | Sale | $31.96 | 153,897 | 4,919,148 | 5,629,842 | Sep 14, 2022, 04:24 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Aug 09, 2022 | Sale | $37.47 | 69,568 | 2,606,713 | 5,753,739 | Aug 10, 2022, 04:22 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Aug 08, 2022 | Sale | $38.33 | 205,000 | 7,857,650 | 5,823,307 | Aug 10, 2022, 04:22 PM |
| Smith L. Mary | Chief Development Officer | Jul 18, 2022 | Option Exercise | $28.47 | 1,551 | 44,157 | 193,076 | Jul 20, 2022, 06:02 PM |
| Burgess Michael F. | Head of Research & Development | Jul 18, 2022 | Option Exercise | $28.47 | 3,103 | 88,342 | 49,584 | Jul 20, 2022, 06:02 PM |
| Burgess Michael F. | Head of Research & Development | Jun 01, 2022 | Option Exercise | $19.61 | 2,672 | 52,398 | 40,502 | Jul 05, 2022, 05:29 PM |
| Nofi Michael | Chief Accounting Officer | Jan 07, 2022 | Option Exercise | $56.06 | 414 | 23,209 | 8,334 | Jan 14, 2022, 04:59 PM |
| Pichl Daniel | Chief People Officer | Jan 07, 2022 | Option Exercise | $56.06 | 631 | 35,374 | 21,667 | Jan 14, 2022, 04:59 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 07, 2022 | Option Exercise | $56.06 | 966 | 54,154 | 19,096 | Jan 14, 2022, 04:58 PM |
| Perier Francis I Jr | Chief Financial Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,307 | 73,270 | 27,502 | Jan 14, 2022, 04:58 PM |
| Smith L. Mary | Chief Development Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,181 | 66,207 | 188,535 | Jan 14, 2022, 04:58 PM |
| Edris Badreddin | Chief Operating Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,852 | 103,823 | 325,813 | Jan 14, 2022, 04:58 PM |
| Islam Saqib | Chief Executive Officer | Jan 07, 2022 | Option Exercise | $56.06 | 3,996 | 224,016 | 853,592 | Jan 14, 2022, 04:57 PM |
| Weinstein Herschel S | General Counsel & Secretary | Jan 07, 2022 | Option Exercise | $56.06 | 1,323 | 74,167 | 18,739 | Jan 11, 2022, 04:04 PM |
| Pichl Daniel | Chief People Officer | Jan 07, 2022 | Option Exercise | $56.06 | 842 | 47,203 | 21,456 | Jan 11, 2022, 04:04 PM |
| Francis Perier I Jr | Chief Financial Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,846 | 103,487 | 26,963 | Jan 11, 2022, 04:04 PM |
| Nofi Michael | Chief Accounting Officer | Jan 07, 2022 | Option Exercise | $56.06 | 567 | 31,786 | 8,181 | Jan 11, 2022, 04:03 PM |
| Smith L. Mary | Chief Development Officer | Jan 07, 2022 | Option Exercise | $56.06 | 1,772 | 99,338 | 187,944 | Jan 11, 2022, 04:03 PM |
| Islam Saqib | Chief Executive Officer | Jan 07, 2022 | Option Exercise | $56.06 | 5,893 | 330,362 | 851,695 | Jan 11, 2022, 04:02 PM |
| Edris Badreddin | Chief Operating Officer | Jan 07, 2022 | Option Exercise | $56.06 | 2,531 | 141,888 | 325,134 | Jan 11, 2022, 04:02 PM |
| Islam Saqib | Chief Executive Officer | Oct 20, 2021 | Sale | $58.67 | 10,083 | 591,527 | 779,218 | Oct 20, 2021, 07:14 PM |
| Islam Saqib | Chief Executive Officer | Oct 19, 2021 | Sale | $58.81 | 14,077 | 827,873 | 769,135 | Oct 19, 2021, 07:27 PM |
| Islam Saqib | Chief Executive Officer | Oct 18, 2021 | Sale | $58.59 | 38,340 | 2,246,505 | 783,212 | Oct 19, 2021, 07:27 PM |
| Smith L. Mary | Chief Development Officer | Oct 13, 2021 | Option Exercise | $2.30 | 10,000 | 23,000 | 177,511 | Oct 13, 2021, 08:24 PM |
| Smith L. Mary | Chief Development Officer | Oct 13, 2021 | Sale | $55.97 | 10,000 | 559,675 | 167,511 | Oct 13, 2021, 08:24 PM |
| Pichl Daniel | Chief People Officer | Sep 08, 2021 | Option Exercise | $43.10 | 2,320 | 99,992 | 9,236 | Sep 09, 2021, 05:15 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Aug 10, 2021 | Sale | $70.25 | 1,000,000 | 70,250,000 | 4,831,307 | Aug 12, 2021, 08:38 PM |
| Islam Saqib | Chief Executive Officer | Jul 20, 2021 | Sale | $77.68 | 18,572 | 1,442,751 | 821,552 | Jul 20, 2021, 07:34 PM |
| Islam Saqib | Chief Executive Officer | Jul 19, 2021 | Sale | $76.09 | 43,928 | 3,342,437 | 840,124 | Jul 20, 2021, 07:34 PM |
| Smith L. Mary | Chief Development Officer | Jul 13, 2021 | Option Exercise | $2.30 | 10,000 | 23,000 | 177,511 | Jul 14, 2021, 04:28 PM |
| Smith L. Mary | Chief Development Officer | Jul 13, 2021 | Sale | $80.88 | 10,000 | 808,777 | 167,511 | Jul 14, 2021, 04:28 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jul 01, 2021 | Sale | $85.01 | 15,959 | 1,356,675 | 6,028,307 | Jul 06, 2021, 04:42 PM |
| Edris Badreddin | Chief Operating Officer | Jul 01, 2021 | Sale | $85.35 | 32,000 | 2,731,088 | 301,541 | Jul 01, 2021, 06:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jun 28, 2021 | Sale | $85.17 | 6,502 | 553,775 | 6,044,266 | Jun 30, 2021, 09:01 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jun 25, 2021 | Sale | $85.14 | 22,334 | 1,901,517 | 6,050,768 | Jun 25, 2021, 07:11 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jun 24, 2021 | Sale | $85.22 | 34,200 | 2,914,524 | 6,073,102 | Jun 25, 2021, 07:11 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jun 23, 2021 | Sale | $85.00 | 100 | 8,500 | 6,107,302 | Jun 25, 2021, 07:11 PM |
| SQUINTO STEPHEN P | Director | Apr 28, 2021 | Sale | $76.20 | 19,231 | 1,465,437 | 125,728 | Apr 28, 2021, 08:18 PM |
| SQUINTO STEPHEN P | Director | Apr 27, 2021 | Sale | $75.05 | 201 | 15,085 | 144,959 | Apr 28, 2021, 08:18 PM |
| Islam Saqib | Chief Executive Officer | Apr 20, 2021 | Sale | $66.39 | 24,075 | 1,598,279 | 884,052 | Apr 20, 2021, 06:51 PM |
| Islam Saqib | Chief Executive Officer | Apr 19, 2021 | Sale | $69.04 | 38,425 | 2,652,827 | 908,127 | Apr 20, 2021, 06:51 PM |
| SQUINTO STEPHEN P | Director | Apr 15, 2021 | Sale | $75.01 | 1,057 | 79,291 | 145,160 | Apr 19, 2021, 06:07 AM |
| SQUINTO STEPHEN P | Director | Apr 14, 2021 | Sale | $75.08 | 511 | 38,365 | 146,217 | Apr 19, 2021, 06:07 AM |
| Smith L. Mary | Chief Development Officer | Apr 13, 2021 | Option Exercise | $2.30 | 10,000 | 23,000 | 177,511 | Apr 13, 2021, 08:21 PM |
| Smith L. Mary | Chief Development Officer | Apr 13, 2021 | Sale | $68.07 | 10,000 | 680,723 | 167,511 | Apr 13, 2021, 08:21 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Mar 09, 2021 | Sale | $71.50 | 1,450,000 | 103,675,000 | 5,831,307 | Mar 11, 2021, 04:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Mar 01, 2021 | Sale | $83.19 | 1,220,000 | 101,491,803 | 6,186,307 | Mar 03, 2021, 06:55 PM |
| Edris Badreddin | Chief Operating Officer | Jan 25, 2021 | Sale | $84.07 | 32,000 | 2,690,281 | 261,542 | Jan 26, 2021, 04:31 PM |
| Smith L. Mary | Chief Development Officer | Jan 20, 2021 | Option Exercise | $2.23 | 10,000 | 22,267 | 177,511 | Jan 21, 2021, 04:31 PM |
| Smith L. Mary | Chief Development Officer | Jan 20, 2021 | Sale | $78.70 | 10,000 | 787,016 | 167,511 | Jan 21, 2021, 04:31 PM |
| Islam Saqib | Chief Executive Officer | Jan 20, 2021 | Sale | $78.75 | 2,199 | 173,180 | 1,222,997 | Jan 21, 2021, 04:30 PM |
| Islam Saqib | Chief Executive Officer | Jan 19, 2021 | Sale | $78.54 | 60,301 | 4,736,209 | 1,225,196 | Jan 21, 2021, 04:30 PM |
| Lewis-Hall Freda C | Director | Sep 17, 2019 | Buy | $18.00 | 50,000 | 900,000 | 4,593,847 | Sep 19, 2019, 07:12 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Sep 17, 2019 | Buy | $18.00 | 275,000 | 4,950,000 | 7,406,307 | Sep 19, 2019, 07:12 PM |
| SQUINTO STEPHEN P | Director | Sep 17, 2019 | Buy | $18.00 | 275,000 | 4,950,000 | 7,406,307 | Sep 19, 2019, 07:12 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Sep 17, 2019 | Buy | $18.00 | 150,000 | 2,700,000 | 7,281,307 | Sep 19, 2019, 07:05 PM |
| PFIZER INC | 10% Owner | Sep 17, 2019 | Buy | $18.00 | 50,000 | 900,000 | 4,593,847 | Sep 19, 2019, 04:19 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Islam Saqib | Chief Executive Officer | 09/03/2024 | 1,988,033 |
| Edris Badreddin | Chief Operating Officer | 09/03/2024 | 812,954 |
| Cassidy James | Chief Medical Officer | 08/30/2024 | 82,127 |
| Cassidy James | Chief Medical Officer | 07/01/2024 | 22,771 |
| Islam Saqib | Chief Executive Officer | 06/03/2024 | 1,955,113 |
| Hambleton Julie | Director | 06/03/2024 | 186,048 |
| Edris Badreddin | Chief Operating Officer | 06/03/2024 | 801,372 |
| Ashar Bhavesh | Chief Commercial Officer | 04/01/2024 | 86,859 |
| Pichl Daniel | Chief People Officer | 02/16/2024 | 414,600 |
| Pichl Daniel | Chief People Officer | 02/16/2024 | 751,549 |
| Ashar Bhavesh | Chief Commercial Officer | 02/05/2024 | 238,435 |
| Ashar Bhavesh | Chief Commercial Officer | 02/02/2024 | 142,976 |
| Pichl Daniel | Chief People Officer | 02/02/2024 | 449,150 |
| Pichl Daniel | Chief People Officer | 02/02/2024 | 1,160,362 |
| Weinstein Herschel S | General Counsel & Secretary | 01/05/2024 | 88,219 |
| Weinstein Herschel S | General Counsel & Secretary | 01/08/2024 | 100,627 |
| Smith L. Mary | Chief Development Officer | 01/08/2024 | 146,809 |
| Smith L. Mary | Chief Development Officer | 01/05/2024 | 83,398 |
| Islam Saqib | Chief Executive Officer | 01/08/2024 | 743,553 |
| Islam Saqib | Chief Executive Officer | 01/05/2024 | 489,115 |
| Pichl Daniel | Chief People Officer | 01/08/2024 | 58,350 |
| Pichl Daniel | Chief People Officer | 01/05/2024 | 59,749 |
| Perier Francis I Jr | Chief Financial Officer | 01/08/2024 | 133,519 |
| Perier Francis I Jr | Chief Financial Officer | 01/05/2024 | 81,652 |
| Nofi Michael | Chief Accounting Officer | 01/08/2024 | 44,146 |
| Nofi Michael | Chief Accounting Officer | 01/05/2024 | 44,375 |
| Edris Badreddin | Chief Operating Officer | 01/08/2024 | 227,003 |
| Edris Badreddin | Chief Operating Officer | 01/05/2024 | 169,643 |
| Cassidy James | Chief Medical Officer | 01/08/2024 | 45,392 |
| Cassidy James | Chief Medical Officer | 01/05/2024 | 89,472 |
| Ashar Bhavesh | Chief Commercial Officer | 01/08/2024 | 60,177 |
| Ashar Bhavesh | Chief Commercial Officer | 01/05/2024 | 95,166 |
| Cassidy James | Chief Medical Officer | 09/01/2023 | 39,186 |
| Hambleton Julie | Director | 07/19/2023 | 70,876 |
| Hambleton Julie | Director | 06/20/2023 | 64,603 |
| Ashar Bhavesh | Chief Commercial Officer | 04/03/2023 | 34,719 |
| Schwartz Jeffrey Lawrence | Director | 03/16/2023 | 49,875,000 |
| Hambleton Julie | Director | 03/15/2023 | 34,841 |
| Pichl Daniel | Chief People Officer | 01/26/2023 | 26,598 |
| Nofi Michael | Chief Accounting Officer | 01/07/2023 | 10,802 |
| Islam Saqib | Chief Executive Officer | 01/07/2023 | 108,202 |
| Edris Badreddin | Chief Operating Officer | 01/07/2023 | 39,166 |
| Pichl Daniel | Chief People Officer | 01/07/2023 | 14,420 |
| Perier Francis I Jr | Chief Financial Officer | 01/07/2023 | 28,787 |
| Smith L. Mary | Chief Development Officer | 01/07/2023 | 28,206 |
| Weinstein Herschel S | General Counsel & Secretary | 01/07/2023 | 24,007 |
| Perier Francis I Jr | Chief Financial Officer | 01/06/2023 | 65,332 |
| Islam Saqib | Chief Executive Officer | 01/06/2023 | 231,168 |
| Edris Badreddin | Chief Operating Officer | 01/06/2023 | 91,532 |
| Cassidy James | Chief Medical Officer | 01/06/2023 | 34,758 |
| Smith L. Mary | Chief Development Officer | 01/06/2023 | 67,479 |
| Nofi Michael | Chief Accounting Officer | 01/06/2023 | 21,548 |
| Ashar Bhavesh | Chief Commercial Officer | 01/06/2023 | 45,821 |
| Weinstein Herschel S | General Counsel & Secretary | 01/06/2023 | 49,041 |
| Pichl Daniel | Chief People Officer | 01/06/2023 | 47,307 |
| Ashar Bhavesh | Chief Commercial Officer | 04/01/2022 | 83,302 |
| ORBIMED ADVISORS LLC | 10% Owner | 09/12/2022 | 4,919,148 |
| ORBIMED ADVISORS LLC | 10% Owner | 08/09/2022 | 2,606,713 |
| ORBIMED ADVISORS LLC | 10% Owner | 08/08/2022 | 7,857,650 |
| Smith L. Mary | Chief Development Officer | 07/18/2022 | 44,157 |
| Burgess Michael F. | Head of Research & Development | 07/18/2022 | 88,342 |
| Burgess Michael F. | Head of Research & Development | 06/01/2022 | 52,398 |
| Nofi Michael | Chief Accounting Officer | 01/07/2022 | 23,209 |
| Pichl Daniel | Chief People Officer | 01/07/2022 | 35,374 |
| Weinstein Herschel S | General Counsel & Secretary | 01/07/2022 | 54,154 |
| Perier Francis I Jr | Chief Financial Officer | 01/07/2022 | 73,270 |
| Smith L. Mary | Chief Development Officer | 01/07/2022 | 66,207 |
| Edris Badreddin | Chief Operating Officer | 01/07/2022 | 103,823 |
| Islam Saqib | Chief Executive Officer | 01/07/2022 | 224,016 |
| Weinstein Herschel S | General Counsel & Secretary | 01/07/2022 | 74,167 |
| Pichl Daniel | Chief People Officer | 01/07/2022 | 47,203 |
| Francis Perier I Jr | Chief Financial Officer | 01/07/2022 | 103,487 |
| Nofi Michael | Chief Accounting Officer | 01/07/2022 | 31,786 |
| Smith L. Mary | Chief Development Officer | 01/07/2022 | 99,338 |
| Islam Saqib | Chief Executive Officer | 01/07/2022 | 330,362 |
| Edris Badreddin | Chief Operating Officer | 01/07/2022 | 141,888 |
| Islam Saqib | Chief Executive Officer | 10/20/2021 | 591,527 |
| Islam Saqib | Chief Executive Officer | 10/19/2021 | 827,873 |
| Islam Saqib | Chief Executive Officer | 10/18/2021 | 2,246,505 |
| Smith L. Mary | Chief Development Officer | 10/13/2021 | 23,000 |
| Smith L. Mary | Chief Development Officer | 10/13/2021 | 559,675 |
| Pichl Daniel | Chief People Officer | 09/08/2021 | 99,992 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 08/10/2021 | 70,250,000 |
| Islam Saqib | Chief Executive Officer | 07/20/2021 | 1,442,751 |
| Islam Saqib | Chief Executive Officer | 07/19/2021 | 3,342,437 |
| Smith L. Mary | Chief Development Officer | 07/13/2021 | 23,000 |
| Smith L. Mary | Chief Development Officer | 07/13/2021 | 808,777 |
| ORBIMED ADVISORS LLC | 10% Owner | 07/01/2021 | 1,356,675 |
| Edris Badreddin | Chief Operating Officer | 07/01/2021 | 2,731,088 |
| ORBIMED ADVISORS LLC | 10% Owner | 06/28/2021 | 553,775 |
| ORBIMED ADVISORS LLC | 10% Owner | 06/25/2021 | 1,901,517 |
| ORBIMED ADVISORS LLC | 10% Owner | 06/24/2021 | 2,914,524 |
| ORBIMED ADVISORS LLC | 10% Owner | 06/23/2021 | 8,500 |
| SQUINTO STEPHEN P | Director | 04/28/2021 | 1,465,437 |
| SQUINTO STEPHEN P | Director | 04/27/2021 | 15,085 |
| Islam Saqib | Chief Executive Officer | 04/20/2021 | 1,598,279 |
| Islam Saqib | Chief Executive Officer | 04/19/2021 | 2,652,827 |
| SQUINTO STEPHEN P | Director | 04/15/2021 | 79,291 |
| SQUINTO STEPHEN P | Director | 04/14/2021 | 38,365 |
| Smith L. Mary | Chief Development Officer | 04/13/2021 | 23,000 |
| Smith L. Mary | Chief Development Officer | 04/13/2021 | 680,723 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 03/09/2021 | 103,675,000 |
| ORBIMED ADVISORS LLC | 10% Owner | 03/01/2021 | 101,491,803 |
| Edris Badreddin | Chief Operating Officer | 01/25/2021 | 2,690,281 |
| Smith L. Mary | Chief Development Officer | 01/20/2021 | 22,267 |
| Smith L. Mary | Chief Development Officer | 01/20/2021 | 787,016 |
| Islam Saqib | Chief Executive Officer | 01/20/2021 | 173,180 |
| Islam Saqib | Chief Executive Officer | 01/19/2021 | 4,736,209 |
| Lewis-Hall Freda C | Director | 09/17/2019 | 900,000 |
| ORBIMED ADVISORS LLC | 10% Owner | 09/17/2019 | 4,950,000 |
| SQUINTO STEPHEN P | Director | 09/17/2019 | 4,950,000 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 09/17/2019 | 2,700,000 |
| PFIZER INC | 10% Owner | 09/17/2019 | 900,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN SPRINGWORKS THERAPEUTICS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 5,619,260 | 0.00479% | 3.32% | Other |
| MAVERICK CAPITAL LTD | 2,600,524 | 1.86% | 36.25% | Growth At A Reasonable Price, Growth |
| ORBIMED ADVISORS LLC | 1,707,331 | 1.27% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,561,058 | 0.00516% | 3.75% | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,283,176 | 1.1% | Exited | Other |
| DUQUESNE FAMILY OFFICE LLC | 1,021,367 | 1.32% | New | Other |
| D. E. SHAW & CO., INC. | 758,712 | 0.03% | 16.93% | Other |
| CANDRIAM S.C.A. | 522,104 | 0.12% | 160.23% | Other |
| SOROS FUND MANAGEMENT LLC | 385,000 | 0.26% | 88.78% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 76,650 | 0.03% | -26.04% | Growth |
| ALPS ADVISORS INC | 52,048 | 0.02% | Exited | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 32,214 | 0.08% | -31.82% | Value |
| AQR CAPITAL MANAGEMENT LLC | 37,413 | 0.00216% | 92.89% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 20,000 (Call) | 0.00149% | New | Value |
| MAGNETAR FINANCIAL LLC | 13,338 | 0.01% | New | Event Driven, Other |
| FARALLON CAPITAL MANAGEMENT LLC | 5,000 | 0.00112% | Exited | Event Driven, Value |
CHANGE IN SHARES OUTSTANDING FOR SPRINGWORKS THERAPEUTICS, INC.
STOCK BUYBACKS FOR SPRINGWORKS THERAPEUTICS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2024
0.48%
1Q
12/31/2023
13.45%
2Q
09/30/2023
18.55%
3Q
06/30/2023
18.66%
4Q
03/31/2023
18.92%
5Q
12/31/2022
19.04%
6Q
09/30/2022
40.11%
7Q
06/30/2022
51.05%
8Q
03/31/2022
51.46%
9Q
12/31/2021
52.08%
10Q
09/30/2021
52.53%
11Q
06/30/2021
53.07%
12Q
03/31/2021
53.68%
13Q
12/31/2020
56.65%
14Q
09/30/2020
75.86%
15Q
06/30/2020
76.71%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SPRINGWORKS THERAPEUTICS, INC.
LOADING...